Neonatal Respiratory Distress Syndrome Treatment Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities

Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

What Is the Projected Growth of the Neonatal Respiratory Distress Syndrome Treatment Market?
The market size for treating neonatal respiratory distress syndrome has witnessed robust growth in the past few years. The market, which stood at $0.96 billion in 2024, is projected to expand to $1.03 billion in 2025, recording a compound annual growth rate (CAGR) of 8.3%. The significant expansion during the past period can be credited to factors such as heightened alveolar-capillary permeability and fluid buildup in the alveoli, a rise in the use of mechanical ventilation devices, enhanced cognizance amongst healthcare providers and parents regarding neonatal care, and increased expenditure on healthcare.

The market for treating neonatal respiratory distress syndrome is projected to witness substantial growth in the upcoming years, expanding to $1.41 billion by 2029 with a compound annual growth rate (CAGR) of 8.0%. This anticipated growth during the forecast period can be ascribed to factors such as the growing favorability for accessories and consumables, an increase in NICU admissions, a rise in the demand for personalized medicine, an uptick in premature births, and escalating research and development undertakings. Key trends to watch for during the forecast period encompass automated processes in neonatal intensive care units (NICUs), the inclusion of artificial intelligence (AI), technological advancements in neonatal care, innovation in surfactant therapy, and improvements in ventilator technologies.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20899

What Are the Different Neonatal Respiratory Distress Syndrome Treatment Market Segments?
The neonatal respiratory distress syndrome treatment market covered in this report is segmented -

1) By Therapy: Oxygen Therapy, Surfactant Therapy
2) By Route Of Administration: Parenteral, Inhalation, Other Routes Of Administration
3) By End User: Hospitals, Sub-Acute Facilities, Home Care, Retail Pharmacies

Subsegments:
1) By Oxygen Therapy: Conventional Oxygen Therapy, High-Flow Nasal Cannula (HFNC) Oxygen Therapy, Continuous Positive Airway Pressure (CPAP) Oxygen Therapy, Invasive Mechanical Ventilation With Oxygen Therapy
2) By Surfactant Therapy: Natural Surfactants, Synthetic Surfactants, Combined Surfactant Therapy (Natural + Synthetic), Prophylactic Surfactant Therapy, Rescue Surfactant Therapy

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20899&type=smp

What Are the Primary Drivers Shaping the Neonatal Respiratory Distress Syndrome Treatment Market?
The growing incidence of premature births is anticipated to drive the expansion of the neonatal respiratory distress syndrome treatment market. Preterm birth, also known as premature birth, occurs when a baby is delivered prior to 37 weeks of gestation. The greatest health dangers are encountered by infants born before 32 weeks, given that a normal pregnancy duration is approximately 40 weeks. The increasing rate of premature births can be attributed to several factors including advanced maternal age, multiple pregnancies, lifestyle choices, health conditions, use of fertility treatments, infections, and environmental aspects. Neonatal respiratory distress syndrome (NRDS) treatment is often needed for preterm babies due to their underdeveloped lungs and insufficient surfactant production. This therapy assists in enhancing lung functionality, stabilizing breathing, and reducing the risk of respiratory failure in prematurely born infants. For example, Tommy's, a UK-based charity organization, reported in December 2022 that the proportion of premature live births in England and Wales increased to 7.9% in 2022 from 7.5% in 2021, marking the second straight year of a rise in premature births. Over 53,000 infants were born prematurely in 2022. As such, the increasing rate of premature births is propelling the growth of the neonatal respiratory distress syndrome treatment market.

Which Companies Are Leading in the Neonatal Respiratory Distress Syndrome Treatment Market?
Major companies operating in the neonatal respiratory distress syndrome treatment market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Abbott Laboratories, Medtronic Plc, Medline Industries, Becton Dickinson, Stryker Corporation, GE Healthcare, Koninklijke Philips NV, ResMed Inc., Drägerwerk AG & Co. KGaA, Chiesi Farmaceutici, ICU Medical Inc., Fisher & Paykel Healthcare, Vyaire Medical, Laerdal Medical, Hamilton Medical, Inspiration Healthcare, Ventec Life Systems, Neotech Products, Aerogen Pharma Corp., Windtree Therapeutics Inc., Discovery Laboratories Inc., Lyomark Pharma GmbH

What Are the Major Trends Shaping the Acellular Dermal Matrices Market?
Leading corporations in the field of neonatal respiratory distress syndrome treatment are investing resources into the advancement of modern technologies such as nitric oxide generators. Their objective is to enhance the process of oxygenation, reduce respiratory issues, and supply non-invasive treatment options for newborns experiencing hypoxic respiratory failure. A nitric oxide generator, often used to address respiratory disorders, is a medical apparatus that produces and administers nitric oxide gas to enhance oxygenation and mitigate pulmonary hypertension specifically in newborns and exceedingly ill patients. To exemplify, Beyond Air Inc., a biopharmaceutical and medical device company stationed in America, obtained FDA approval in June 2022 for LungFit PH. This state-of-the-art nitric oxide generator is tailored to manage term and near-term newborns suffering from hypoxic respiratory failure, including persistent pulmonary hypertension of the newborn (PPHN). This device, built on Beyond Air's proprietary Ionizer technology, produces nitric oxide directly from surrounding air, guaranteeing an unlimited reserve without worrying about dosage or flow. Additionally, it employs a low-power compressor to ionize nitrogen and oxygen, thus reducing the production of nitrogen dioxide (NO2), which is then efficiently filtered out through a smart filter.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/neonatal-respiratory-distress-syndrome-treatment-global-market-report

What Are the Top Revenue-Generating Geographies in the Neonatal Respiratory Distress Syndrome Treatment Market?
North America was the largest region in the neonatal respiratory distress syndrome treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neonatal respiratory distress syndrome treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Neonatal Respiratory Distress Syndrome Treatment Market?
2. What is the CAGR expected in the Neonatal Respiratory Distress Syndrome Treatment Market?
3. What Are the Key Innovations Transforming the Neonatal Respiratory Distress Syndrome Treatment Industry?
4. Which Region Is Leading the Neonatal Respiratory Distress Syndrome Treatment Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.